Madhav Vasanthavada - 01 Jan 2026 Form 3 Insider Report for ABEONA THERAPEUTICS INC. (ABEO)

Role
Chief Commercial Officer
Signature
/s/ Madhav Vasanthavada
Issuer symbol
ABEO
Transactions as of
01 Jan 2026
Net transactions value
$0
Form type
3
Filing time
26 Jan 2026, 16:31:17 UTC
Next filing
26 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vasanthavada Madhav Chief Commercial Officer 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND /s/ Madhav Vasanthavada 26 Jan 2026 0002106295

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABEO Common Stock 254,608 01 Jan 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ABEO Employee Stock Option (right to buy) 01 Jan 2026 Common Stock 2,400 $4.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 176,384 shares of unvested restricted stock, which vest on various dates between January 21, 2026 and January 21, 2028.
F2 The option becomes exercisable as to 600 shares on June 15, 2023, and in 36 equal monthly installments thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney